Invention Grant
- Patent Title: Antibody-drug conjugates and the use of same in therapy
-
Application No.: US14904353Application Date: 2014-07-11
-
Publication No.: US10307488B2Publication Date: 2019-06-04
- Inventor: Nicolas Joubert , Marie Claude Viaud-Massuard , Renaud Respaud
- Applicant: UNIVERSITE FRANCOIS RABELAIS
- Applicant Address: FR Tours
- Assignee: UNIVERSITE FRANCOIS RABELAIS
- Current Assignee: UNIVERSITE FRANCOIS RABELAIS
- Current Assignee Address: FR Tours
- Agency: Young & Thompson
- Priority: FR1356837 20130711
- International Application: PCT/FR2014/051802 WO 20140711
- International Announcement: WO2015/004400 WO 20150115
- Main IPC: A61K51/00
- IPC: A61K51/00 ; A61M36/14 ; A61K47/48 ; C07D207/456 ; C07K16/32 ; A61K49/00 ; A61K51/02 ; C07K16/28 ; C07K16/40 ; C12N9/10 ; C12N9/24 ; A61K47/65 ; A61K47/68
Abstract:
Disclosed are novel antibody-drug conjugates and use thereof in therapy, in particular in anticancer or anti-inflammatory therapy, as well as synthetic products useful as linkers, composed of a linker head and a linker body, and also a method for preparing the linkers and the antibody-drug conjugates.
Public/Granted literature
- US20160151515A1 NOVEL ANTIBODY-DRUG CONJUGATES AND THE USE OF SAME IN THERAPY Public/Granted day:2016-06-02
Information query
